As of 2026-09-15, the Relative Valuation of Gossamer Bio Inc (GOSS) is (397.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.70 USD, the upside of Gossamer Bio Inc based on Relative Valuation is -3816.1%.
The range of the Relative Valuation is (370.60) - (455.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 23.6x | 21.4x |
| Forward P/E multiples | 15.9x - 23.7x | 19.8x |
| Fair Price | (370.60) - (455.52) | (397.62) |
| Upside | -3563.5% - -4357.2% | -3816.1% |
| Date | P/E |
| 2026-09-11 | -0.56 |
| 2026-09-10 | -0.59 |
| 2026-09-09 | -0.66 |
| 2026-09-08 | -0.75 |
| 2026-09-04 | -0.73 |
| 2026-09-03 | -0.73 |
| 2026-09-02 | -0.72 |
| 2026-09-01 | -0.69 |
| 2026-08-31 | -0.70 |
| 2026-08-28 | -0.71 |
| 2026-08-27 | -0.71 |
| 2026-08-26 | -0.72 |
| 2026-08-25 | -0.85 |
| 2026-08-24 | -0.73 |
| 2026-08-21 | -0.64 |
| 2026-08-20 | -0.65 |
| 2026-08-19 | -0.65 |
| 2026-08-18 | -0.59 |
| 2026-08-17 | -0.58 |
| 2026-08-14 | -0.64 |
| 2026-08-13 | -0.71 |
| 2026-08-12 | -0.74 |
| 2026-08-11 | -0.75 |
| 2026-08-10 | -0.73 |
| 2026-08-07 | -0.74 |
| 2026-08-06 | -0.74 |
| 2026-08-05 | -0.74 |
| 2026-08-04 | -0.75 |
| 2026-08-03 | -0.72 |
| 2026-07-31 | -0.70 |
| 2026-07-30 | -0.74 |
| 2026-07-29 | -0.86 |
| 2026-07-28 | -0.85 |
| 2026-07-27 | -0.83 |
| 2026-07-24 | -0.56 |
| 2026-07-23 | -0.59 |
| 2026-07-22 | -0.60 |
| 2026-07-21 | -0.64 |
| 2026-07-20 | -0.58 |
| 2026-07-17 | -0.71 |
| 2026-07-16 | -0.71 |
| 2026-07-15 | -0.67 |
| 2026-07-14 | -0.58 |
| 2026-07-13 | -0.60 |
| 2026-07-10 | -0.70 |
| 2026-07-09 | -0.73 |
| 2026-07-08 | -0.70 |
| 2026-07-07 | -0.74 |
| 2026-07-06 | -0.81 |
| 2026-07-02 | -0.72 |